Myringitis

Also known as: Unspecified myringitis / Unspecified myringitis, unspecified ear / Tympanic membrane inflammation / Tympanitis / Myringitis NOS / Myringitis (disorder)

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB00281	Lidocaine	A local anesthetic used in a wide variety of superficial and invasive procedures.

Drug	Drug Name	Target	Type
DB00281	Lidocaine	Sodium channel protein type 5 subunit alpha	target
DB00281	Lidocaine	Sodium channel protein type 10 subunit alpha	target
DB00281	Lidocaine	Epidermal growth factor receptor	target
DB00281	Lidocaine	Sodium channel protein type 9 subunit alpha	target
DB00281	Lidocaine	Cytochrome P450 1A2	enzyme
DB00281	Lidocaine	Cytochrome P450 2D6	enzyme
DB00281	Lidocaine	Cytochrome P450 3A4	enzyme
DB00281	Lidocaine	Cytochrome P450 3A5	enzyme
DB00281	Lidocaine	Cytochrome P450 3A7	enzyme
DB00281	Lidocaine	Solute carrier family 22 member 5	transporter
DB00281	Lidocaine	P-glycoprotein 1	transporter
DB00281	Lidocaine	Cytochrome P450 2A6	enzyme
DB00281	Lidocaine	Cytochrome P450 2B6	enzyme
DB00281	Lidocaine	Cytochrome P450 2C8	enzyme
DB00281	Lidocaine	Cytochrome P450 2C9	enzyme
DB00281	Lidocaine	Sodium channel protein type 4 subunit alpha	target
DB00281	Lidocaine	Alpha-1-acid glycoprotein 1	target
DB00281	Lidocaine	Alpha-1-acid glycoprotein 2	target

Drug	Drug Name	Phase	Status	Count